You are using an older browser version. Please use a supported version for the best MSN experience.

BIO-TECHNE CORPORATION

NASDAQ: TECH
340.34
-12.10
-3.43%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Biotechnology & Medical Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 738.69M

    • Net Income

    • 229.07M

    • Market Cap.

    • 13.61B

    • Enterprise Value

    • 13.64B

    • Net Profit Margin %

    • 31.04

    • PEG (Price/Earnings Growth) Ratio

    • 4.05

    • Beta

    • 1.11

    • Forward P/E

    • 61.30

    • Price/Sales

    • 0.00

    • Price/Book Value

    • 9.81

    • Price/Cash flow

    • 43.61

      • EBITDA

      • 233.50M

      • Return on Capital %

      • 12.48

      • Return on Equity %

      • 18.99

      • Return on Assets %

      • 12.48

      • Book Value/Share

      • 37.29

      • Shares Outstanding

      • 38.61M

      • Last Split Factor (Date)

      • 2:1 (12/4/2000)

      • Last Dividend (Ex-Date)

      • 0.32 (8/17/2020)

      • Dividend Declaration Date

      • 8/4/2020

      Analyst Recommendation
      1/26/2021
      Buy
        • 1 Year Price Target

        • 320.00

        • Analysts

        • 9

        • EPS Estimate

        • 5.70

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • 11.44

        • 12.48

        • Net Income

          YTD/YTD (Last Year)

        • 138.70

        • 6.37

        • Net Income

          Q/Q (Last Year)

        • 133.22

        • -30.43

        • Sales (Revenue)

          5-Year Annual Average

        • 10.31

        • -

        • Net Income

          5-Year Annual Average

        • 16.28

        • -

        • Dividends

          5-Year Annual Average

        • 0.16

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • 65.41

        • 61.36

        • Pre-Tax Margin

        • 37.43

        • -21.22

        • Net Profit Margin

        • 31.04

        • -16.28

        • Average Gross Margin

          5-Year Annual Average

        • 66.50

        • 64.07

        • Average Pre-Tax Margin

          5-Year Annual Average

        • 24.51

        • -0.93

        • Average Net Profit Margin

          5-Year Annual Average

        • 18.97

        • -5.04

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • 56.27

        • 56.27

        • P/E Ratio 5-Year High

        • 84.49

        • -

        • P/E Ratio 5-Year Low

        • 40.29

        • -

        • Price/Sales Ratio

        • 18.42

        • 11.14

        • Price/Book Value

        • 9.81

        • 7.65

        • Price/Cash Flow Ratio

        • 43.61

        • 28.19

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Biotechnology & Medical Research
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 0.22

        • 0.46

        • Current Ratio

        • 5.14

        • 3.36

        • Quick Ratio

        • 3.92

        • 2.99

        • Leverage Ratio

        • 1.43

        • 2.02

        • Book Value/Share

        • 37.29

        • 1.49

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 75.23

          • Key Metrics

          • Company

            • Payout Ratio

            • 19.78

            • Dividend Date

            • 8/4/2020

            • Ex-Dividend Date

            • 8/17/2020

            • Last Split Factor

              new per old

            • 2:1

            • Last Split Date

            • 12/4/2000

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • 18.99

              (11.54)

            • -16.46

              (-4.04)

            • Return on Assets %

              (5-Year Average)

            • 12.48

              (7.77)

            • -7.57

              (-1.77)

            • Return on Capital %

              (5-Year Average)

            • 13.12

              (8.24)

            • -9.66

              (-2.14)

            • Income/Employee

            • 100.79k

            • -74.34k

            • Inventory Turnover

            • 2.63

            • 2.87

            • Asset Turnover

            • 0.38

            • 0.37

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon